Intra-mural research funding
The University Medical Center Mainz supports its (early-career) researchers in pursuing innovative and pioneering research projects. Applicants can choose between the following three different intra-mural funding options:
Medical Minds Mainz: Awards for early-career researchers in various categories
High-Potentials Grant: multi-year funding to develop your own research profile
Clinical Research Fellowships: support of clinical research for clinician scientists
currently suspended:
Stufe I: Start-up funding for third-party funded projects
Stufe I - currently suspended
Please note:At the moment, to apply for an intra-mural Stufe I research funding is unfortunatley not possible.
Medical Minds Mainz: awards for Young Researchers in various categories
The next call announcement will be published in early spring 2025.
- Friederike Kirschner, Institute of Immunology, for the work: „Modulation of cellular transcriptome and proteome composition by azidohomoalanine—implications on click chemistry–based secretome analysis“
- Kristin Grunz, Center for Thrombosis and Hemostasis (CTH), for the work: „Nucleic acid sensing promotes inflammatory monocyte migration through biased coagulation factor VIIa signaling“
- Ioannis Farmakis, Center for Thrombosis and Hemostasis (CTH), for the work: „Lipid lowering for prevention of venous thromboembolism: a network meta analysis“
Clara-Sophie Schwarz, Institute of Legal Medicine, for the work: „Rechtsmedizinische Sachverständigentätigkeit in der öffentlichen Wahrnehmung“
- Miriam Heuser, Translational Animal Research Center (TARC) ,for the work: „A 3D-Printed Dummy for Training Distal Phalanx Amputation in Mice“
- Nicholas Hanuscheck, Klinik und Poliklinik für Neurologie, for the work „Interleukin-4 receptor signaling modulates neuronal network activity“
- Anke Adenäuer, Institut für klinische Chemie und Laboratoriumsmedizin, for the work „Severe high-molecular-weight kininogen deficiency: clinical characteristics, deficiency–causing KNG1 variants, andestimated prevalence“
- Dr. med. Simon J. Gairing, I. Medizinische Klinik und Poliklinik, for the work „ Prevalence of Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Multicenter Study “
In 2023, this prize was not awarded
- In 2023, this prize was not awarded
- Kevin Jan Legscha, III. Medizinische Klinik und Poliklinik, for the work „Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity“
- Katie Frenis, PhD, Zentrum für Kardiologie, for the work „Ablation of lysozyme M-positive cells prevents aircraft noise-induced vascular damage without improving cerebral side effects“
- Luís Miguel Ferreira de Almeida, PhD, Institut für Medizinische Mikrobiologie und Hygiene, for the work „Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis“
- Dr. med. Lukas Müller, M.D., Klinik und Poliklinik für Diagnostische und Interventionelle Radiologie, for the work „Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC“
Herrn Oliver Bayer, Frau Maike Dienst, Frau Alexandra Euler, Herrn Emmanuel Gbogbo, Herrn Kai Günther, Frau Juliane Haase, Frau Alisha Hall, Frau Katrin Maria Kopp, Frau Anna Mavromanoli, Frau Tabea Petelkau, Frau Laura Pfrommer, Frau Julia Popow, Herrn Nicola Riccetti, Frau Ida Scholz, Frau Yanita Simeonova, Frau Nina Teletzky, Frau Marielle Wirth, Herrn Dr. Emilio Gianicolo sowie Frau Univ.-Prof. Dr. Susanne Singer, Institut für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI) mit dem Masterstudiengang Epidemiologie, für die Arbeit „Epi… Was?“ – Fragen und Antworten zur Epidemiologie“
- Priv.-Doz. Dr. med. Naureen Keric, Neurochirurgische Klinik und Poliklinik, for the work „Ein in vitro Clot-Modell der spontanen intrazerebralen Blutung zur Optimierung der minimal-invasiven Therapie"
- Dr. rer. nat. Jan-Sebastian Boegel, I. Medizinische Klinik und Poliklinik, for the work „Current status of use of high throughput nucleotide sequencing in rheumatology“
- Marin Kuntic, Zentrum für Kardiologie, for the work „Short-term e-cigarette vapour exposure causes vascular oxidative stress and dysfunction: evidence for a close connection to brain damage and a key role of the phagocytic NADPH oxidase (NOX-2)“
- Dr. rer. nat. Nadine Baumgart, Translational Animal Research Center (TARC), for the work „Proaktive Kommunikation über Tierversuche“
- Miriam Pons, Institut für Toxikologie, for the work „Human Platelet Lysate as Validated Replacement for Animal Serum to Assess Chemosensitivity“
High Potentials Grant: multiannual funding to develop own research profile
The grant is awarded to outstanding post-doctoral scientists with a doctorate (clinician scientists or medical scientists) from Germany and abroad, who have already distinguished themselves with high-ranking publications, their own third-party funding and proven their potential as independent scientists.
The previous High Potentials Grant Fellows of the University Medical Center Mainz are presented on this page.
Purpose and aim of the fellowship
This grant is intended to give the candidates the opportunity to establish themselves as independent researchers with their own research profile and to achieve their academic independence - ideally by establishing their own research group and/or by being appointed as a (junior) professor. During the grant, candidates are expected to acquire significant third-party funding.
Successful candidates will be employed at the University Medical Center (UMC) Mainz. A funding of €100,000 p.a. to finance their own position and further project costs will be available to the candidates for a duration of 3 years. Clinician scientists who, due to their clinical obligations, only apply for funding of their proportionate employment (at least 50%) by these means can apply for a cost-neutral extension of the funding period to a maximum of 4 years.
The candidates will be advised by two mentors (if applicable, a clinician scientist and a basic researcher), who actively support them in achieving the scientific and professional goals as well as the milestone plan described in their proposal. At least one of the mentors must be employed at the UMC, while the second may belong to another institution.
The candidates may take part in the advanced training program of the Mainz Research School of Translational Biomedicine. A mandatory prerequisite for an application is the commitment of the Department head to finance the applicant’s position after the end of the intramural funding for the duration of the third party-funded project, in case the financing of a third-party funded project has been successfully obtained. In this regard, please note that the regulations of the Wissenschaftszeitvertragsgesetzes (WissZeitVG) apply.
Eligibility information
Medical and clinician scientists with “Habilitation” are not eligible.
For clinician scientists, the directorate of their host institute is required to release the candidate of their clinical commitment for at least 50% of their working time for the duration of the fellowship. This will have to be confirmed by the host institute directorate and will be verified during the funding period.
Clinician scientists and medical scientists who are already permanently employed at UMC are eligible for a High Potentials Grant. However, the host institute is required to explicitly outline how it will ensure the long-term support of the career of the candidate after the funding by the High Potentials Grant ends.
Application procedure
The application process has two stages. Candidates are nominated by potential mentors from the UMC. The Vice Dean for Research, supported by the Committee for Research Funding (AFF) and external reviewers, makes the decision on inviting full proposals and awarding the High Potentials Grant. Direct applications are not accepted.
A specified catalog of criteria (PDF 233,1 KB) is used to assess the candidates and their proposal in both stages of the review process by the AFF and external reviewers, respectively.
- All candidates use this template for
- Academic CV,
- List of publications, including impact factor,
- List of previously applied for and attracted third-party funding,
- Title and short description of the planned project, and
- Short description of the career perspective after the grant funding period.
- Additional documents (for all candidates):
- Form declaring times of special burdens,
- Signed data privacy statement, and
- Institutional support form – signed by mentor and host institution.
- Additional document for clinician scientists only:
- Signed declaration by the institute directorate to release the candidate of their clinical commitment for at least 50% of their working time.
- Additional document for candidates with permanent employment at UMC only:
- Description of host institute on how it will support the research career of the candidate after the granting period ends.
2. Stage: Full proposals must be sent electronically to prodekan-forschung.um@uni-mainz.de (tentative deadline mid of March). Based on at least two external reviews and supported by the AFF, the Vice Dean for Research will select candidates for an interview. A maximum of two candidates will be awarded.
Required document (in English):
- Full proposal (use this template).
The interim evaluation of the project takes place 18 months after the start of funding and is also carried out by the AFF. For the interim evaluation, the achievement of the milestones set out in the application as well as any third-party funding acquired is assessed.
Clinical Research Fellowships
Mainz University Medical Center has set itself the goal of promoting active initiation and participation in academically driven clinical trials. In order to increase the attractiveness of clinical research for young, excellent physicians, to create career perspectives, to increase the visibility of the University Medical Center and finally to translate this knowledge into advances in patient care, a scholarship program has been established.The fellowship is intended as temporary start-up funding for clinical research projects.
